Debut Plus

₹23.33

▼ -1.02 -4.19%

As of 23 Oct 2026 · delayed

BSE Listed

GSM · GSM 1
What does GSM · GSM 1 mean?
BSE · Graded Surveillance Measure (GSM 1)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).Exchange notice · 2026-07-20

Saptak Chem & Business Ltd. (506906)

Volume: 145Avg Vol 1W: 319Avg Vol 1M: 1,22152W Range:₹12.89₹64.13
Key Ratios
Checked 1h ago
Market Cap₹7 Cr
Current Price₹23.33
Previous Close₹24.35
High / Low (52w)₹64.13 / ₹12.89
Volume145
Avg Vol (1W)319
Avg Vol (1M)1,221
Stock P/E—
Book Value₹-1.49
Dividend Yield0%
ROE20.02%
ROA-26.09%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding0 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹34.94
200 DMA₹39.19
Day change-4.19%
SurveillanceGSM · GSM 1
Price Chart
₹23.33▲ 77.55% · 1Y
₹63₹454K
2025-10-27
2026-10-23

20-day avg volume: 1K shares

Pros
  • Healthy return on equity of 20.0%.
  • Company is almost debt-free.
  • Revenue grew 333% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS0.01-0.01-0.020.010.01-0.03-0.08-2.81
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹0 Cr₹0 Cr₹1 Cr
Total Liabilities₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹2 Cr₹2 Cr₹3 Cr
Equity₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹-1 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹1 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹-1 Cr
Shareholding
Promoter 4.39% Institutions 0% Public 95.61%
Efficiency & Working Capital
ROCE-26.4%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-09-30

Promoter4.4%
FII0%
DII0%
Institutions0%
Public95.6%
Promoter Pledge0%
No. of Shareholders2,064
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters16.3%16.3%16.3%16.3%16.3%16.3%16.3%12.6%12.6%12.6%4.4%4.4%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs3%3%3%3%3%3%3%0%0%0%0%0%
Public80.7%80.7%80.7%80.7%80.7%80.7%80.7%87.4%87.4%87.4%95.6%95.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders10,95210,95210,95210,95212,50112,54612,5202,3902,3902,2182,2222,064
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Jayshree JainPublic Shareholding16.3%5,00,000
Hmm Consultancy LlpPublic Shareholding16.3%5,00,000
Akshay Shah (huf)Public Shareholding16.3%5,00,000
Ankush Agarwal HufPublic Shareholding16.3%5,00,000
Saptak ChemPublic Shareholding8.4%2,59,001
Alpha Antibiotics LimitedShareholding of Promoter and Promoter Group4.4%1,35,000
Tvisha Corporate Advisors LlpPublic Shareholding1.3%40,900
Deep Health Ai India LimitedPublic Shareholding1.3%40,000
Navneet KaurPublic Shareholding1.3%39,157
Munak Engineers Pvt. Ltd.Shareholding of Promoter and Promoter Group0%0
Keshoram Leasing LtdShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Bhoomiben PatelIndependent Non Exe. Director2026
Sonal Deepalbhai GandhiIndependent Non Exe. Director2026
Jignesh Keshav BarotIndependent Non Exe. Director2026
Rinku SainiIndependent Non Exe. Director2026
Jubin Premji GadaIndependent Non Exe. Director2026
Ajay Suresh YadavIndependent Non Exe. Director2026
Ayush Vinod Kumar TatedExecutive Director & MD2026
Krishna BhavsarCompany Sec. & Compli. Officer2026
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹101111
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-01Board Meetings—
forthcoming—Book ClosureAGM
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000000
2026000000
2026000000
Company Information
Incorporated1980
AuditorP H Shah & Co
🌐 www.saptakchem.com ↗

📍 C-608 Shyam Parisar Nr Dhwani, Heights 8/h Municipal School, Ahmedabad, Gujarat, 382443

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search